Results 201 to 210 of about 80,532 (301)

Next-generation multiplex-edited CAR-NK cells: more edits, more power? [PDF]

J Immunother Cancer
Bexte T, Wagner DL.
europepmc   +1 more source

Immunomodulatory effects of photodynamic therapy for skin cancer: Potential strategies to improve treatment efficacy and tolerability

Photochemistry and Photobiology, EarlyView.
Photodynamic therapy (PDT) is a nonscarring treatment modality that is widely used for skin cancers and early squamous precursor lesions. PDT was previously thought to work primarily by killing cancer cells directly (via apoptosis or necrosis). However, more recent work indicates that a significant mechanism for PDT is the stimulation of anti‐cancer ...
Mark P. Ortenzio, Sanjay Anand, Jeffrey B. Travers, Edward V. Maytin, Craig A. Rohan   +4 more
wiley   +1 more source

Precision targeting of rhabdomyosarcoma by combining primary CAR NK cells and radiotherapy. [PDF]

J Immunother Cancer
Reindl LM, Jalili L, Bexte T, Harenkamp S, Thul S, Hehlgans S, Wallenwein A, Rothweiler F, Cinatl J, Michaelis M, Bonig H, Gradhand E, Vogler M, Rödel F, Wels WS, Ullrich E.   +15 more
europepmc   +1 more source

Inflammation and mechanical force‐induced bone remodeling

Periodontology 2000, EarlyView.
Abstract Periodontitis arises from imbalanced host–microbe interactions, leading to dysbiosis and destructive inflammation. The host's innate and adaptive immune responses produce pro‐inflammatory mediators that stimulate destructive events, which cause loss of alveolar bone and connective tissue attachment.
Hyeran Helen Jeon, Xin Huang, Leticia Rojas Cortez, Puttipong Sripinun, Jung‐me Lee, Julie J. Hong, Dana T. Graves   +6 more
wiley   +1 more source

Targeting CSPG4 enhances the anti-tumor activity of CAR-NK cells for glioblastoma. [PDF]

Cell Oncol (Dordr)
Xiong Q, Yin B, Jiang H, Qiu Y, Shi G, Xu J, Xu T, Deng H.   +7 more
europepmc   +1 more source

The Troll Is Weakened but Not yet Defeated: An Update on Cytomegalovirus Management in Transplantation From the International CMV Symposium 2025

Transplant Infectious Disease, EarlyView.
This review synthesizes discussions from the 2025 International CMV Symposium on translating three recently updated international guidelines into clinical practice across solid organ and hematopoietic stem cell transplantation, highlighting advances in risk‐stratified prevention, emerging therapies, immune monitoring, and persistent implementation ...
Camille N. Kotton, Martina Sester, Julian Torre‐Cisneros, The International CMV Symposium Faculty   +3 more
wiley   +1 more source

Disarming a molecular brake: cAMP-responsive element modulator deletion supercharges CAR-NK cells. [PDF]

Signal Transduct Target Ther
Hebbar Subramanyam S, Tenbrock K.
europepmc   +1 more source

Variability between countries in cytokine responses to BCG vaccination: what impact might this have on protection?

, 2012
Dockrell, Hazel M, Lalor, Maeve K, Smith, Steven G   +2 more
core   +1 more source

Fine-tuning signal strength in CD5 CAR-NK cells for targeted T cell cancer therapy. [PDF]

Front Immunol
Jo S, Lee YB, Kim SM, Lee SY, Choi M, Kyun ML, Jeong SY, Lee S, Kim JH, Kim Y, Kim YJ, Park S, Moon KS, Kim TD.   +13 more
europepmc   +1 more source

Erratum: Efficiently targeting neuroblastoma with the combination of anti-ROR1 CAR NK cells and N-803 <i>in vitro</i> and <i>in vivo</i> in NB xenografts. [PDF]

Mol Ther Oncol
Chu Y, Nayyar G, Tian M, Lee DA, Ozkaynak MF, Ayala-Cuesta J, Klose K, Foley K, Mendelowitz AS, Luo W, Liao Y, Ayello J, Behbehani GK, Riddell S, Cripe TP, Cairo MS.   +15 more
europepmc   +1 more source